Lipid peroxidation, antioxidants and cardiovascular disease: How should we move forward?

Cardiovascular Research

Volumn 47, Issue 3, 2000, Pages 410-418

  Halliwell, Barry ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Coronary disease; Free radicals

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKER; ISOPROSTANE;

ANALYTIC METHOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET; DRUG EFFECT; HEART PROTECTION; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COLORIMETRY; DIET; DIETARY SUPPLEMENTS; DINOPROST; FRUIT; HUMANS; LIPID PEROXIDATION; PROTEIN ISOFORMS; RESEARCH DESIGN; VEGETABLES;

EID: 0034682916     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00097-3     Document Type: Review

References (134)

1. La Vecchia C., De Carli A., Pagano R. Vegetable consumption and risk of chronic disease. Epidemiology. 9:1998;208-210.
2. Rimm E.B., Ascherio A., Giovannucci E., Spiegelman D., Stampfer M.J., Willett W.C. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. J Am Med Assoc. 275:1996;447-451.
3. Lloyd T., Chinchilli V.M., Rollings N., et al. Fruit consumption, fitness and cardiovascular health in female adolescents: the Penn State Young women's Health Study. Am J Clin Nutr. 67:1998;624-630.
4. Singh R.B., Rastogi V., Rastogi S.S., Niaz M.A., Beegom R. Effect of diet and moderate exercise on central obesity and associated disturbances, myocardial infarction and mortality in patients with and without coronary artery disease. J Am Coll Nutr. 15:1996;592-601.
5. Renaud S., Guenguen R. The French paradox and wine drinking. Novartis Foundation Symp. 216:1998;208-217.
6. De Lorgeril M., Salen P., Martin J.-L., Moniaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart study. Circulation. 99:1999;779-785.
7. Albert C.M., Manson J.E., Cook N.R., et al. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation. 100:1999;944-950.
8. Sesso H.D., Gaziano J.M., Buring J.E., Hennekens C.H. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol. 149:1999;162-167.
9. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, ed. 3, Oxford: Oxford University Press, Oxford, 1999.
10. Wiseman S.A., Balentine D.A., Frei B. Antioxidants in tea. Crit Rev Food Sci Nutr. 37:1997;705-718.
11. Frankel E.N., Waterhouse A.L., Teissedre P.L. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low density lipoproteins. J Agr Food Chem. 43:1995;890-894.
12. Paganga G., Miller N., Rice-Evans C.A. The polyphenolic content of fruits and vegetables and their antioxidant activities. What does a serving constitute? Free Rad Res. 30:1999;153-162.
13. Gey K.F. Vitamins E plus C and interacting nutrients required for optimal health. Biofactors. 7:1998;113-174.
14. Lampe J.W. Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr. 70:(Suppl.):1999;475S-490S.
15. Rosenfeld M.E. Inflammation, lipids and free radicals: lessons learned from the atherogenic process. Semin Reprod Endocrinol. 16:1998;249-261.
16. Steinberg D., Lewis A. Oxidative modification of LDL and atherogenesis. Circulation. 95:1997;1062-1071.
17. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 79:1999;609-634.
18. Ferrari R., Agnoletti L., Comini L., et al. Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J. 19:(Suppl. B):1998;B2-11.
19. 2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 100:1997;2028-2034.
20. 2α in pericardial fluid of patients with heart failure. Circulation. 97:1998;1536-1539.
21. Dietary supplementation with polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 54:1999;447-455.
22. Stephens N.G., Parsons A., Schofield M., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
23. Vitamin E supplementation and cardiovascular events in high risk patients. New Engl J Med. 342:2000;154-160.
24. Hsieh T.C., Juan G., Darzynkiewicz Z., Wu J.M. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/C1P1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59:1999;2596-2601.
25. Pietinen P., Rimm E.B., Korhonen P., et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. Circulation. 94:1996;2720-2727.
26. Brouwer I.A., Van Dusseldorp M., West C.E., et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr. 129:1999;1135-1139.
27. Woodside J.V., Yarnell J.W., McMaster D., et al. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinaemia: a double-blind, randomised, factorial-design, controlled trial. Am J Clin Nutr. 67:1998;858-866.
28. Al-Abed Y., Mitsuhashi T., Li H., et al. Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol. Proc Natl Acad Sci USA. 96:1999;2385-2390.
29. Kris-Etherton P.M., Yu-Poth S., Sabaté J., Ratcliffe H.E., Zhao G., Etherton T.D. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 70:(Suppl.):1999;504S-511S.
30. Albanes D. Beta-carotene and lung cancer: a case study. Am J Clin Nutr. 69:1999;13455-13505.
31. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev. 57:1999;104-113.
32. Poulsen H.E., Loft S., Prieme H., et al. Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Rad Res. 29:1998;565-571.
33. Loft S., Thorling E.B., Poulsen H.E. High fat diet induced oxidative DNA damage estimated by 8OHdG excretion in rats. Free Rad Res. 29:1998;595-600.
34. Asami S., Hirano T., Yamaguchi R., Itoh H., Kasai H. Reduction of 8-hydroxyguanine in human leukocyte DNA by physical exercise. Free Rad Res. 29:1998;581-584.
35. Deng X.S., Tuo J., Poulsen H.E., et al. Prevention of oxidative DNA damage in rats by Brussels sprouts. Free Rad Res. 25:1998;323-333.
36. Okamura K., Doi T., Sakurai M., et al. Effect of endurance exercise on the tissue 8-hydroxydeoxyguanosine content in dogs. Free Rad Res. 26:1997;523-528.
37. Rehman A., Bourne L.C., Halliwell B., Rice-Evans C.A. Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun. 262:1999;828-831.
38. Beatty E.R., England T.G., Geissler C.A., Aruoma O.I., Halliwell B. Effects of antioxidant vitamin supplementation on markers of DNA damage and plasma antioxidants. Proc Nutr Soc. 58:1999;44A.
39. Thompson H.J., Heimendinger J., Haegele A., et al. Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. Carcinogenesis. 20:1999;2261-2266.
40. Smith M.J., Inserra P.F., Watson R.R., Wise J.A., O'Neill K.L. Supplementation with fruit and vegetable extracts may decrease DNA damage in the peripheral lymphocytes of an elderly population. Nutr Res. 19:1999;1507-1518.
41. Klaunig J.E., Xu Y., Gan C., et al. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med. 220:1999;249-254.
42. Pool-Zobel B.L., Bub A., Muller H., Wollowski I., Rechkemmer G. Consumption of vegetables reduces genetic damage in humans: first results of an intervention trial with carotenoid-rich foods. Carcinogenesis. 18:1997;1847-1850.
43. Ascherio A., Rimm E.B., Hernan M.A., et al. Relation of consumption of vitamin E, vitamin C and carotenoids to risk for stroke among men in the US. Ann Int Med. 130:1999;963-970.
44. Rimm E.B., Stampfer M.J. The role of antioxidants in preventive cardiology. Curr Opin Cardiol. 12:1997;188-194.
45. Liu S., Ajani U., Chae C., Hennekens C., Buring J.E., Manson J.A. Long-term β-carotene supplementation and risk of type 2 diabetes mellitus. J Am Med Assoc. 282:1999;1073-1075.
46. Tornwall M.A., Virtamo J., Haukka J.K., et al. The effect of α-tocopherol and β-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial. Atherosclerosis. 147:1999;193-197.
47. Klipstein-Grobusch K., Geleijnse J.M., den Brecijèn J.H., et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr. 69:1999;261-266.
48. Ness A.R., Chee D., Elliott P. Vitamin C and blood pressure - an overview. J Human Hypertens. 11:1997;343-350.
49. Bates C.J., Walmsley C.M., Prentice A., Finch S. Does vitamin C reduces blood pressure? Results of a large study of people aged 65 or older. J Hypertens. 16:1998;925-932.
50. Aminbakhsh A., Mancini J. Chronic antioxidant use and changes in endothelial dysfunction: a review of clinical investigations. Can J Cardiol. 15:1999;895-903.
51. Ceriello A. Vitamin C and endothelial dysfunction: what is new? Circulation. 99:1999;1273-1274.
52. Duffy S.J., Gokce N., Holbrook M., et al. Treatment of hypertension with ascorbic acid. Lancet. 354:1999;2048-2049.
53. Hinz B., Schroder H. Vitamin C attenuates nitrate tolerance independently of its antioxidant effect. FEBS Lett. 428:1998;97-99.
54. Kushi L.H. Vitamin E and heart disease: a case study. Am J Clin Nutr. 69:(Suppl.):1999;1322S-1329S.
55. Brown M. Do vitamin E and fish oil protect against ischaemic heart disease? Lancet. 354:1999;441-442.
56. Stahl W., Junghans A., de Boer B., Driomina E.S., Briviba K., Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett. 427:1998;305-308.
57. Halliwell B. The antioxidant paradox. Lancet. 355:2000;1179-1180.
58. McCall M.R., Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Rad Biol Med. 26:1999;1034-1053.
59. Halliwell B. Vitamin C: poison, prophylactic or panacea? TIBS. 24:1999;255-259.
60. Ivanov V.O., Raborsky A.B., Ivanova S.V., Niedzwiecki A. Transforming growth factor β1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms. Atherosclerosis. 110:1998;25-34.
61. Azzi A., Aratri E., Boscoboinik D., et al. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors. 7:1998;3-14.
62. Gokce N., Keaney J.F. Jr., Frei B., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 99:1999;3234-3240.
63. Kappus H., Diplock A.T. Tolerance and safety of vitamin E: a toxicological position report. Free Rad Biol Med. 13:1992;55-74.
64. Devaraj S., Jialal I. Alpha-tocopherol decreases 1L-1β release from activated human monocytes by inhibition of 5-lipoxygenase. Arterio Thromb Vasc Biol. 19:1999;1125-1133.
65. Miller E.R. III, Appel L.J., Risby T.H. Effect of dietary patterns on measures of lipid peroxidation. Circulation. 98:1998;2390-2395.
66. Honinger I., Chopra M., Thurnham D.I., et al. Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers. Eur J Clin Nutr. 51:1997;601-606.
67. Parks E.J., German J.B., Davis P.A., et al. Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment programme. Am J Clin Nutr. 68:1998;775-785.
68. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr. 57:1993;715S-725S.
69. Esterbauer H., Puhl M., Dieber-Rothender M., et al. Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23:1991;573-581.
70. Porkkala-Sarataho E.K., Nyyssonen M.K., Kaikkonen J.E., et al. A randomised single-blind placebo-controlled trial of the effects of 200 mg α-tocopherol on the oxidation resistance of atherogenic lipoproteins. Am J Clin Nutr. 68:1998;1034-1041.
71. Rimm E.B., Stampfer M.J., Ascherio A., et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1456.
72. Cherubini A., Beal M.F., Frei B. Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Free Rad Biol Med. 27:1999;381-387.
73. Van het Hof K.H., de Boer H.S.M., Wiseman S.H., et al. Consumption of green or black tea does not increase resistance of LDL to oxidation in humans. Am J Clin Nutr. 66:1997;1125-1132.
74. Princen H.M.G., van Duyvenvoorde W., Buytenhek R., et al. No effect of consumption of green and black teas on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterio Thromb Vasc Biol. 18:1998;833-841.
75. de Rijke Y.B., Demacher P.N., Assen N.A., Sloots L.M., Katan M.B., Stalenhof A.F. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am J Clin Nutr. 63:1996;329-334.
76. Misca L., Rubenfire M., Tarshis T., Tsai A., Pearson T. Clinical predictors of oxidized LDL in patients with coronary artery disease. Am J Cardiol. 80:1997;825-830.
77. Nigdikar S.V., Williams N.R., Griffin B.A., Howard A.N. Consumption of red wine polyphenols reduces the susceptibility of LDL to oxidation in vivo. Am J Clin Nutr. 68:1998;258-265.
78. Stein J.H., Kevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary heart disease. Circulation. 100:1999;1050-1055.
79. Aviram M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular disease. Free Rad Res 2000, in press.
80. Smith C., Michinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J. 286:1992;901-905.
81. Ferns G.A., Lamb D.J., Taylor A. The possible role of copper ions in atherogenesis: the blue Janus. Atherosclerosis. 133:1997;139-152.
82. Fu S., Davies M.J., Stocker R., Dean R.T. Evidence for role of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J. 333:1998;519-525.
83. Steinberg D. At last, direct evidence that lipoxygenase plays a role in atherosclerosis. J Clin Invest. 103:1999;1487-1488.
84. Luoma J.S., Stralin P., Marklund S.L., et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 18:1998;157-167.
85. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in LDL isolated from human atherosclerotic intima. J Clin Invest. 99:1997;2075-2081.
86. Rice-Evans C., Leake D., Bruckdorfer K.R., Diplock A.T. Practical approaches to LDL oxidation: whys, wherefores and pitfalls. Free Rad. Res. 25:1996;285-311.
87. Yla-Herttuala S. Is oxidized LDL present in vivo? Curr Opin Lipidol. 9:1998;337-344.
88. Lehtimaki T., Lehtinen S., Solakivi T., et al. Autoantibodies against oxidized LDL in patients with angiographically verified coronary artery disease. Arterio Thromb Vasc Biol. 19:1999;23-27.
89. Frei B., Yamamoto Y., Niclas D., Ames B.N. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem. 175:1998;120-130.
90. Arai H., Terao J., Abdalla D.S.P., Suzuki T., Takama K. Coulometric detection in HPLC analysis of cholesteryl ester hydroperoxides. Free Rad Biol Med. 20:1996;365-371.
91. Pastorino A.M., Zamburlini A., Zennaro L., Maiorino M., Ursini F. Measurement of lipid hydroperoxides in human plasma and lipoproteins by analysis of photon emission. Meth Enzymol. 300:1999;33-43.
92. Wilson R., Smith R., Wilson P., Shepherd M.J., Riemersma R.A. Quantitative GC-MS isomer-specific measurement of hydroxy fatty acids in biological samples and food as a marker of lipid peroxidation. Anal Biochem. 248:1997;76-85.
93. Nikkari T., Malo-Ranta U., Hiltunen T., Jaakkola O., Yla-Herttuala S. Monitoring of lipoprotein oxidation by gas chromatographic analysis of hydroxy fatty acids. J Lipid Res. 36:1995;200-207.
94. Yeo H.C., Helbock H.J., Chyu D.W., Ames B.N. Assay of MDA in biological fluids by GC-MS. Anal Biochem. 220:1994;391-396.
95. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-HNE, MDA and related aldehydes. Free Rad Biol Med. 11:1991;81-128.
96. Cighetti G., Debiasi S., Paroni R., Allevi P. Free and total malondialdehyde assessment in biological matrices by GC-MS: what is needed for an accurate detection. Anal. Biochem. 266:1999;222-229.
97. Brown E.D., Morris V.C., Rhodes D.G., et al. Urinary malondialdehyde equivalents during ingestion of meat cooked at high or low temperatures. Lipids. 30:1995;1053-1056.
98. Grootveld M., Atherton M.D., Sheerin A.N., et al. In vivo absorption, metabolism, and urinary excretion of β-unsaturated aldehydes in experimental animals. J Clin Invest. 101:1998;1210-1218.
99. Aw T.Y. Determinants of intestinal detoxication of lipid hydroperoxides. Free Radic Res. 25:1998;637-646.
100. Staprans I., Rapp J.H., Pan X.M., Feingold K.R. The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats. J Clin Invest. 92:1993;638-643.
101. Richelle M., Turini M.E., Guidoux R., et al. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett. 459:1999;259-262.
102. Kneepkens C.M.F. Assessment of oxidative stress and antioxidant status in humans: the hydrocarbon breath test. Aruoma O.I. Antioxidant methodology. 1997;23 American Oil Chemists Society, Indianapolis.
103. Mendis S., Sobotka P.A., Euler D.E. Expired hydrocarbons in patients with acute myocardial infarction. Free Rad Res. 23:1995;117-122.
104. Knutson M.D., Lim A.K., Viteri F.E. A practical and reliable method for measuring ethane and pentane in expired air from humans. Free Rad Biol Med. 27:1999;560-571.
105. Lawson J.A., Rokach J., FitzGerald G.A. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem. 247:1999;24441-24444.
106. Roberts L.J. II, Morrow J.D. The generation and actions of isoprostanes. Biochim Biophys Acta. 1345:1997;121-135.
107. 2α is increased in hypercholesterolaemia. Arterio Thromb Vasc Biol. 17:1997;3230-3235.
108. 2-isoprostanes) in smokers. N Engl J Med. 332:1995;1198-1203.
109. 2-isoprostanes in hypercholesterolaemia. Circulation. 98:1998;2822-2828.
110. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 94:1996;19-25.
111. 2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem. 268:1999;117-125.
112. 2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/GC-MS. Basal levels in smokers and non-smokers. Free Rad Biol Med. 20:1996;619-624.
113. Montuschi P., Corradi M., Ciabattoni G., et al. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Resp Crit Care Med. 160:1999;216-220.
114. 2α levels are elevated in individuals with NIDDM. FEBS Lett. 368:1995;225-229.
115. 2α and platelet activation in diabetics mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 99:1999;224-229.
116. 2α. FEBS Lett. 428:1998;32-36.
117. Practico D., Tangirala R., Radar D.J., et al. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in Apo E-deficient mice. Nature Med. 4:1998;1189-1192.
118. 2α. Hypertension. 33:1999;424-428.
119. 2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis. 147:1999;1-10.
120. 2-isoprostanes in human urine. Proc. Natl. Acad. Sci. USA. 96:1999;13381-13386.
121. 2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Rad Res 2000, in press.
122. 2-isoprostane and lipid peroxide levels. Free Rad Biol Med. 28:2000;806-814.
123. Voutilainen S., Morrow J.D., Roberts L.J. II, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterio Thromb Vasc Biol. 19:1999;1263-1266.
124. Palmer A.M., Thomas C.R., Gopaul N., et al. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia. 41:1998;148-156.
125. 2-isoprostanes in aging kidneys. Am J Physiol. 274:1998;R767-R774.
126. Boger R.H., Bode-Boger S.M., Phivthong-ngam L., et al. Dietary L-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis. 141:1998;31-43.
127. Laight D.W., Kengaatharan K.M., Gopaul N.K., Änggård E.E., Carrier M.J. Investigation of oxidant stress and vasodepression to glyceryl trinitrate in the obese Zucker rat in vivo. Br J Pharmacol. 125:1998;895-901.
128. 2-isoprostanes) are not correlated in healthy human subjects. Free Rad Res. 32:2000;355-362.
129. Roberts L.J. II, Montine T.J., Markesbery W.R., et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 273:1998;13605-13612.
130. 3-isoprostanes during peroxidation of eicosapentaenoic acid. Biochem Biophys Res Commun. 236:1997;467-472.
131. 4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid. Biochem Biophys Res Commun. 242:1998;338-344.
132. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Rad Res. 31:1999;261-272.
133. Roxborough HE, Burton GW, Kelly FJ. Inter and intra-individual variation in plasma and red cell vitamin E after supplementation. Free Rad Res 2000, in press.
134. Halliwell B. Antioxidants and measures of lipid oxidation. In: Proc Workshop on Markers of Oxidative Damage and Antioxidant Protection: Relation to Health and Wellbeing, ILS1 Europe, Prague, 1999:30.